ABSTRACT
Objective To estimate the prevalence of overweight/obesity at 12 months in an Italian birth cohort and to identify factors related to an increased likelihood of being overweight.
Methods The Italian NASCITA birth cohort was analysed. Infants were classified as underweight (<5th), normal weight (5th-85th), and overweight (>85th centile) at 12 months of age according to the World Health Organization percentiles of body mass index and the prevalence of overweight/obesity was estimated. To test the association between the chance of being overweight/obese and parental and newborn characteristics, and infant feeding, healthy newborns (no preterm/low birth weight, and with no malformations), with appropriate-for-gestational-age birth weight were selected, and univariate and multivariate analyses were performed
Results The prevalence of overweight was 23.5% (95%CI 22.2-24.8) in the 4,270 neonates followed during their first year of life, and 23.7% (631/2749) in healthy newborns with a birth weight that was appropriate for gestational age.
A big infant appetite (Odds Ratio 4.39, 95%CI: 2.73-7.07), living in southern Italy (OR 1.64, 95%CI: 1.35-2.00) and maternal age <30 years (OR 1.39, 95%CI: 1.05-1.83) were the main variables associated with a greater likelihood of being overweight/obese. Exclusive breastfeeding for at least 6 months did not influence the chance of being overweight.
Conclusions The sociodemographic factors (e.g. area of residence, age) seem to be the most relevant determinants influencing the chance of being overweight. In order to prevent childhood and adult obesity, early interventions should be set up or improved, with particular attention to vulnerable families.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://clinicaltrials.gov/ct2/show/NCT03894566
Funding Statement
This work was supported by resources from the Laboratory for Mother and Child Health and by an economic contribution by the Associazione Amici del Mario Negri. The Associazione Amici del Mario Negri had no role in the design and conduct of the study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Fondazione IRCCS Istituto Neurologico "Carlo Besta" ethics committee (Verbale n 59, 6th February 2019,) and informed consent was obtained from the newborns' parents.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* A complete list of NASCITA Working group members appears in the acknowledgments.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.